510(k) Report

510(k) · Cleared

Cleared

Home Access Aic Test

K141944510(k) TraditionalCleared Mar 13, 2015239-day reviewClass II21 CFR 864.7470

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Home Access Health Corp. · LCP Assay, Glycosylated Hemoglobin

Cleared on Mar 13, 2015 as substantially equivalent to K990899 (Osborn Group, Inc., 1999) after a 239-day review. Its family tree reaches back 4 generations to 1986. 2 later devices descend from it.

Decided
Mar 13, 2015
Review
239 days
Class
Class II
Product code
LCP
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K861697 (1986). 2 later devices descend from it, 2 citing it directly.

  1. Root · 4 generations backK861697 Self Assure/GHB (Capillary-Blood Collection Kit)Awareness Technology, Inc. · 1986
  2. 3 generations backK971919 Ezchek/Hba Blood Collection KitFlexsite Diagnostics, Inc. · 1997
  3. 2 generations backK984529 Hemochek Sample Collection KitOsborn Laboratories, Inc. · 1999
  4. 1 generation backK990899 Hemochek-A1C Sample Collection KitOsborn Group, Inc. · 1999 · Recalled
  5. This deviceK141944 Home Access Aic TestHome Access Health Corp. · 2015
  6. Descendant · cites it directly · 0 of its ownK231465 Q-Pad Test SystemQurasense · 2023
  7. Descendant · cites it directly · 0 of its ownK183230 OneDraw A1C Test SystemDrawbridge Health, Inc. · 2019

Most influential descendants

Showing 2 of 2 · See all
  • K231465Q-Pad Test SystemQurasense · 2023 · cites it directly0descendants
  • K183230OneDraw A1C Test SystemDrawbridge Health, Inc. · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K861697Self Assure/GHB (Capillary-Blood Collection Kit)Awareness Technology, Inc.1986—
−3K971919Ezchek/Hba Blood Collection KitFlexsite Diagnostics, Inc.1997—
−2K984529Hemochek Sample Collection KitOsborn Laboratories, Inc.1999—
−1K990899Hemochek-A1C Sample Collection KitOsborn Group, Inc.199934
0 (this device)K141944Home Access Aic TestHome Access Health Corp.2015—
+1K231465Q-Pad Test SystemQurasense2023—
+1K183230OneDraw A1C Test SystemDrawbridge Health, Inc.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202310
FIG. 1 — Lineage of K141944, 1986–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LCP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LCP device

  1. #1 K221326 Nova Allegro HbA1c Assay, Nova Allegro Analyzerscore 9.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K990899Hemochek-A1C Sample Collection Kit
Summary page 4
…ES Proprietary Name: HemoChek-A1c Sample Collection Kit (sold under the brand ReliOn A1c Test) 510(k) Number: K990899 Classification Name: Assay, glycosylated hemoglobin Regulation Number: 21 CFR §864.7470 Product Code:…
Osborn Group, Inc.199934
†K063852Accessa Cholesterol PanelHome Access Health Corp.2007—
†K961274Olympus AU600 Clinical Chemistry AnalyzerOlympus America, Inc.19967
†K031380Olympus HBA1C Reagent, (Catalog Number OSR6192), Olympus HBA1C Calibrator, (Catolog…Olympus America, Inc.20031

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231465Q-Pad Test SystemQurasense20230
K183230OneDraw A1C Test SystemDrawbridge Health, Inc.20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 5 companies; a new generation was cleared every 11.0 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K231465 (Qurasense, 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LCP devices

LCP Assay, Glycosylated Hemoglobin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · LCP

1in 2024

2007: 72008: 52009: 62010: 22011: 102012: 92013: 22014: 82015: 32016: 22017: 52018: 22019: 42020: 12023: 22024: 1
2007high 10 (2011) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LCP

269in 2019

2007: 133 days median2008: 206 days median2009: 158 days median2011: 176 days median2012: 143 days median2014: 127 days median2015: 239 days median2017: 218 days median2019: 269 days median
2007high 269 (2019) · low 127 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LCP

1in 2025

2007: 12008: 32009: 62010: 52011: 512013: 42014: 22015: 22016: 62017: 12018: 12022: 12024: 12025: 1
2007high 51 (2011) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LCP

22in 2025

2007: 52008: 112009: 152010: 42011: 272012: 512013: 1932014: 1822015: 642016: 292017: 1492018: 1,9112019: 1142020: 132021: 72022: 82023: 272024: 392025: 22
2007high 1,911 (2018) · low 4 (2010)2025

MAUDE reports naming product code LCP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007713315
20085206311
20096158615
20102—54
2011101765127
20129143051
20132—4193
201481272182
20153239264
20162—629
201752181149
20182—11,911
201942690114
20201—013
20210—07
20220—18
20232—027
20241—139
20250—122
20260—0—

What is it indicated for?

The Home Access® A1C Test is an in vitro test method for the quantitative measurement of Hemoglobin Alc using capillary blood collected from the fingertip, collected onto filter paper via the Home Access collection cassette. The Home Access A1C Test is for measurement of HbAlc on blood specimens which can be collected at the patient's home or in a healthcare professional setting and delivered to the laboratory by mail. Measurements obtained through this method can be used for monitoring the long-term control of blood sugar (glucose) in people with diabetes.

This test is not to be used to diagnose or screen for diabetes. Not for use on neonates.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K141944: Home Access Aic Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141944

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026